Cargando…
Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()()
• Cutaneous metastases are rare and clinically challenging to manage. When present, they often represent end-stage disease. • Treatments for cutaneous metastases are limited, and primarily palliative in nature.
Autores principales: | Craig, Christine D., Iglesias, David A., Watkins, Jack, Coleman, Robert L., Kilgore, Larry, Ramirez, Pedro T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862230/ https://www.ncbi.nlm.nih.gov/pubmed/24371701 http://dx.doi.org/10.1016/j.gynor.2013.05.005 |
Ejemplares similares
-
Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009) -
Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006) -
Prolonged use of pegylated liposomal doxorubicin in gynecologic malignancies
por: Yost, S., et al.
Publicado: (2019) -
Pegylated liposomal doxorubicin in the management of ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2010) -
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
por: Yuan, Zhen, et al.
Publicado: (2021)